Panbela Therapeutics

Biotechnology, Health Care, Pharmaceutical
Founded in 1/1/11
Minnesota City, Minnesota, United States
http://www.sunbiopharma.com
For Profit

About Panbela Therapeutics

Panbela Therapeutics is a next-generation biopharmaceutical company developing disruptive therapeutics for serious unmet medical needs. The company’s initial programs are aimed at diseases of the pancreas, including pancreatic cancer and pancreatitis. Panbela Therapeutics has scientific collaborations with pancreatic disease experts at Honor Health in Scottsdale, Arizona, Cedars Sinai Medical Center in Los Angeles, the University of Minnesota, Mayo Clinic Scottsdale, the Austin Health Cancer Trials Centre, and the Ashford Cancer Centre in Adelaide, Australia. Founded in 2011, the company is based in Minnesota, United States.

Company Metrics

  • Employees: 1-10
  • Monthly Visits: None
  • Tech Stack: 8 active products

Financial Information

  • Estimated Revenue: Less than $1M
  • Total Funding: 43884898 USD
  • Last Funding: 15000000 USD (Post-IPO Equity)
  • Funding Status: IPO

Technology Stack

Panbela Therapeutics actively uses 8 products in their tech stack.

Market Presence

Industries: Biotechnology, Health Care, Pharmaceutical

Headquarters: Minnesota City, Minnesota, United States